Effect of recreational therapy in patients with breast cancer

ISRCTN ISRCTN17247097
DOI https://doi.org/10.1186/ISRCTN17247097
Submission date
12/07/2024
Registration date
12/07/2024
Last edited
12/07/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Breast cancer is one of the most common malignant tumors in women. This study aimed to observe the effect of recreational therapy on anxiety and depression and quality of life in patients with breast cancer undergoing radiotherapy.

Who can participate?
Female patients aged 20 - 65 years with breast cancer undergoing radiotherapy.

What does the study involve?
160 patients were randomly divided into intervention group (n = 82) and control group (n = 78). The patients in the two groups were investigated by questionnaire. The intervention group was treated with recreational therapy during radiotherapy for about 30 days. Patients in the control group were routinely got nursing education about radiotherapy knowledge and self-care methods after admission. Follow-up was conducted 1 month after surgery.

What are the possible benefits and risks of participating?
Recreational therapy can effectively reduce the negative emotions of anxiety and depression in patients with breast cancer during radiotherapy after radical mastectomy, and Recreational therapy has a significant effect on the quality of life in the field of overall health status.

Where is the study run from?
The Fourth Hospital of Hebei Medical University (China)

When is the study starting and how long is it expected to run for?
May 2012 to December 2013

Who is funding the study?
Key Science and Technology Research Program of Health Commission of Hebei Province (No. 20150809) (China)

Who is the main contact?
Junli Liang, nienannan@126.com

Contact information

Dr Junli Liang
Public, Scientific, Principal Investigator

No. 12 of Jiankang Road, Chang’an District
Shijiazhuang
050011
China

ORCiD logoORCID ID 0009-0004-7443-4466
Phone +86-311 8609 5225
Email nienannan@126.com

Study information

Study designSingle-centre interventional randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet No participant information sheet available
Scientific titleEffect of recreational therapy on psychological status and quality of life in patients with breast cancer undergoing radiotherapy
Study objectivesRecreational therapy can effectively reduce the negative emotions of anxiety and depression in patients with breast cancer during radiotherapy after radical mastectomy, and Recreational therapy has a significant effect on the quality of life in the field of overall health status.
Ethics approval(s)

Approved 17/11/2021, Ethics Committee of The Fourth Hospital of Hebei Medical University (No. 12 of Jiankang Road, Chang’an District, Shijiazhuang, 050011, China; +86-31186095784; hb4thgcp@126.com), ref: 2021145

Health condition(s) or problem(s) studiedPrevention of anxiety and depression and improvement of quality of life in patients with breast cancer undergoing radiotherapy
Intervention160 patients were randomly (using a computer-generated table of random numbers) divided into intervention group (n = 82) and control group (n = 78). The patients in the two groups were investigated by questionnaire. The intervention group was treated with recreational therapy during radiotherapy for about 30 days. Patients in the control group routinely got nursing education about radiotherapy knowledge and self-care methods after admission.

Intervention typeBehavioural
Primary outcome measureAt baseline and follow-up (1 month after surgery):
1. General demographic characteristics collected by questionnaire
2. Anxiety measured by Self-rating anxiety scale (SAS)
3. Depression measured by Self-Rating Depression Scale (SDS)
4. Quality of life measure by EORTC Cancer Quality of Life Core Scale (QLQ-C30) and Breast Cancer Specific Scale (QLQ-BR23)
Secondary outcome measuresThere are no secondary outcome measures.
Overall study start date01/05/2012
Completion date31/12/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit20 Years
Upper age limit50 Years
SexFemale
Target number of participants200
Total final enrolment160
Key inclusion criteria1. Female patients after modified radical mastectomy
2. Married, aged ≤50 years
3. KPS score ≥70 points
4. Patients with normal cognition, reading and writing ability, informed consent, voluntary participation in the survey of the first radiotherapy
Key exclusion criteria1. Combined with other malignant tumors
2. Severe liver and kidney dysfunction
3. Previous history of mental illness or personality disorders, nearly a month have taken antipsychotic drugs
4. Unmarried, divorced, widowed
5. Spouses during the illness of patients with major diseases
Date of first enrolment30/06/2012
Date of final enrolment31/12/2012

Locations

Countries of recruitment

  • China

Study participating centre

The Fourth Hospital of Hebei Medical University
No. 12 of Jiankang Road, Chang’an District
Shijiazhuang
050011
China

Sponsor information

The Fourth Hospital of Hebei Medical University
Hospital/treatment centre

No. 12 of Jiankang Road, Chang’an District
Shijiazhuang
050011
China

Phone +86-311 8609 5588
Email hb4thgcp@126.com

Funders

Funder type

Government

Key Science and Technology Research Program of Health Commission of Hebei Province

No information available

Results and Publications

Intention to publish date30/07/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Junli Liang (nienannan@126.com).

Editorial Notes

12/07/2024: Trial's existence confirmed by the Ethics Committee of The Fourth Hospital of Hebei Medical University.